Articles Archives - Page 372 of 714

ThursdayJul 22, 2021 9:30 am

ISW Holdings Inc. (ISWH) Updates Shareholders on Crypto Mining, Convertible Debt and SEC Filing Status

Company taking active steps to eliminate debt, ramp up growth, open access to shares ISWH signs agreement with GPL Ventures to eliminate over $2.4 million in convertible promissory notes Company has started mining and expects to reach larger objectives laid out for mining progress and results in 2021 ISW Holdings (OTC: ISWH), a global brand management holdings company, has released a shareholder update on the status of its convertible debt resolution process, mining operations and upcoming audit results (https://ibn.fm/67Wqm). The company currently has commercial operations in telehealth and renewable energy cryptocurrency mining. “We continue to work hard every day to…

ThursdayJul 22, 2021 9:24 am

FingerMotion Inc. (FNGR) Releases Q1 2022 Reports Showing Continuing Upward Growth Trend

FingerMotion (FNGR) a rapidly evolving tech company serving markets in China, announced its financial results for the period Q1 2022 The company generated $6.00 million in revenue, representing the fourth consecutive quarter of record revenue The Telecommunications Products & Services (mobile recharge platform) and the SMS & MMS texting service sectors continued to show strong growth FingerMotion (OTCQX: FNGR) is a rapidly evolving tech company focused on its core competencies of mobile payment and recharge platform serving markets in China. The company announced its financial results for the period Q1 2022. Sectors that continued to show an upward growth graph…

ThursdayJul 22, 2021 9:00 am

Ideanomics Inc.’s (NASDAQ: IDEX) Sales To Finance to Charging (S2F2C) Business Model Paves Way For Exponential Growth Opportunities

Ideanomics’s EV market is expected to grow exponentially, driven by growing public awareness/acceptance and the U.S. administration’s support The company plans its expansion moves across three strong EV pillars: vehicles, charging, and energy IDEX acquisition of California-based Solectrac reflects the company’s approach to an electric tractor revolution In 2020, the number of global electric vehicles reached the 10 million mark, with battery electric vehicles (“EVs”) being the main force behind the expansion. The governments of many countries provided fiscal incentives that have acted as a catalyst for the new registration of electric cars (https://ibn.fm/zu2U7). Ideanomics (NASDAQ: IDEX), is a global…

ThursdayJul 22, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Set to Preview Milestones for Novel Psychedelic Therapies in Investor Day Event

Tryp Therapeutics is a drug developer whose mission is to find novel solutions to conditions with otherwise unmet needs The company has distinguished itself by developing a synthetic oral psilocybin product that it aims to use in the treatment of chronic pain and eating disorder indications under its psychedelic medicine research program Tryp’s management team will address investors in a Fiscal Q3 review on July 29 that also serves as an opportunity to talk about upcoming milestones for the company Venture capital investment interest in psychedelic therapies has grown explosively from $1 million in 2017 to $329 million during the…

WednesdayJul 21, 2021 9:30 am

The DeFi Conference 2021 Tackles The Challenges of the Decentralized Finance Industry

5th August 2021 Pricing-Free The Decentralized Finance (“DeFi”) Industry offers a vast set of opportunities and has its set of challenges, with market finance volatility and risks increasing accordingly. The DeFi Conference 2021 is being held on 5th August 2021. This one-day free online event is a great learning and informative platform for businesses, academics, investors, and entrepreneurs to better understand the decentralized finance industry and explore the opportunities that this space offers. The DeFi Conference 2021 is organized by Bitcoin Events, a pioneer events company that hosts world-class bitcoin and blockchain conferences in Africa. The event will bring forth…

WednesdayJul 21, 2021 9:30 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Begin Patient Dosing in Berubicin Phase 2 Clinical Trial During Q3 2021, and Received Fast Track Designation from FDA

CNS Pharmaceuticals has been granted FDA Fast Track Designation for Berubicin due to the serious unmet medical need for new GBM treatments Enrollment into the potentially pivotal study for Berubicin and glioblastoma multiforme (“GBM”) in adults is already underway CNS Pharmaceuticals also secures additional funding of $4.7 million for pivotal study and operations into Q2 2022, adding to company’s significant accomplishments in short time CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, achieved several fundamental clinical, corporate, and regulatory milestones over the…

WednesdayJul 21, 2021 9:00 am

Friendable Inc. (FDBL) Reports Major Milestone of 5,000 Fan Pass Artist Sign-ups, Shares New Corporate Presentation

The new version of the Fan Pass platform (v2.0) for mobile and desktop is scheduled for release one year after its debut, with new and improved offerings outlined in a new corporate presentation Artists and fans both benefit from the updated version, gaining an easy-to-use dashboard that tracks ticket and merchandise sales (for artists) and special access into the lives of the artists (for fans) Friendable estimates that if three celebrity partners with 10 million followers each marketed the Fan Pass platform and 1% of those followers subscribed, that would bring 300,000 new subscribers to the artist streaming platform A…

WednesdayJul 21, 2021 9:00 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Looks to Leverage Position in Growing Infused-Cannabis Space

New numbers project that cannabis beverage market will reach $2.8 billion by 2025 Increasing demand for the health and wellness drinks is contributing to market growth BevCanna’s scalable, flexible manufacturing process provides white label solutions for third-party companies A new report that forecasts the cannabis beverage market will grow at 17.85% CAGR by 2025 has companies such as BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) anticipating increased numbers as well (https://ibn.fm/zh9Pa). A leader in the space, BevCanna is looking to leverage its position in the growing market as a white label manufacturer of infused-cannabis beverage brands. According to a…

WednesdayJul 21, 2021 9:00 am

Keynote Speaker Presentations from SRAX Inc.’s (NASDAQ: SRAX) 2021 Sequire Blockchain Conference Now Available on Demand

2021 Sequire Blockchain Conference presentations now available on demand Conference featured over 15 established and emerging companies across blockchain, cryptocurrency spaces Keynote speakers included Brock Pierce, Maja Vujinovic, Saum Noursalehi, George Stella, Brittany Kaiser SRAX (NASDAQ: SRAX), a leading financial technology company that helps public companies unlock the power of data through its Sequire SaaS platform, recently hosted the 2021 Sequire Blockchain Conference (https://ibn.fm/fTW6e), featuring over 15 leading blockchain and cryptocurrency-focused companies along with a slew of industry experts, including Brock Pierce, Maja Vujinovic, Saum Noursalehi, George Stella and Brittany Kaiser. Brock Pierce is a prominent entrepreneur, philanthropist, blockchain pioneer,…

TuesdayJul 20, 2021 9:30 am

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Announces New Board Appointment

Former head of psychiatry products at FDA joins Cybin team. Laughren will help company plot its regulatory pathway as it studies and develops psychedelic medicines. Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, is making strategic moves as it progresses with pre-clinical and clinical trials. One of those steps includes the company’s recent announcement that Thomas Laughren is joining Cybin’s clinical advisory board (https://ibn.fm/q0abz). A medical doctor who served as the director of the U.S. Food and Drug Administration’s division of psychiatry products for nearly three decades, Laughren will help the company plot its regulatory…

Site Search

Company Search

Category: Articles

ISW Holdings Inc. (ISWH) Updates Shareholders on Crypto Mining, Convertible Debt and SEC Filing Status

FingerMotion Inc. (FNGR) Releases Q1 2022 Reports Showing Continuing Upward Growth Trend

Ideanomics Inc.’s (NASDAQ: IDEX) Sales To Finance to Charging (S2F2C) Business Model Paves Way For Exponential Growth Opportunities

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Set to Preview Milestones for Novel Psychedelic Therapies in Investor Day Event

The DeFi Conference 2021 Tackles The Challenges of the Decentralized Finance Industry

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Begin Patient Dosing in Berubicin Phase 2 Clinical Trial During Q3 2021, and Received Fast Track Designation from FDA

Friendable Inc. (FDBL) Reports Major Milestone of 5,000 Fan Pass Artist Sign-ups, Shares New Corporate Presentation

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Looks to Leverage Position in Growing Infused-Cannabis Space

Keynote Speaker Presentations from SRAX Inc.’s (NASDAQ: SRAX) 2021 Sequire Blockchain Conference Now Available on Demand

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Announces New Board Appointment

Market Basics

Newsletter Publishers

Public Companies